Detalles de la búsqueda
1.
Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction.
N Engl J Med
; 390(17): 1560-1571, 2024 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38587254
2.
Efficacy and Safety of Dapagliflozin in Type 2 Diabetes According to Baseline Blood Pressure: Observations From DECLARE-TIMI 58 Trial.
Circulation
; 145(21): 1581-1591, 2022 05 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-35510542
3.
Inhibition of p38 MAP kinase in patients with ST-elevation myocardial infarction - findings from the LATITUDE-TIMI 60 trial.
Am Heart J
; 243: 147-157, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34508693
4.
Risk markers of incident atrial fibrillation in patients with coronary heart disease.
Am Heart J
; 233: 92-101, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33400910
5.
Rationale and design of ApoA-I Event Reducing in Ischemic Syndromes II (AEGIS-II): A phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy and safety of CSL112 in subjects after acute myocardial infarction.
Am Heart J
; 231: 121-127, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33065120
6.
Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trial.
Eur Heart J
; 41(44): 4245-4255, 2020 11 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-33051646
7.
Status of PCSK9 Monoclonal Antibodies in Australia.
Heart Lung Circ
; 28(10): 1571-1579, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31104887
8.
Clinical features and outcomes of patients with type 2 myocardial infarction: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial.
Am Heart J
; 196: 28-35, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29421012
9.
Effects of genetic variation in protease activated receptor 4 after an acute coronary syndrome: Analysis from the TRACER trial.
Blood Cells Mol Dis
; 72: 37-43, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30055940
10.
Visit-to-visit variability of blood pressure and cardiovascular outcomes in patients with stable coronary heart disease. Insights from the STABILITY trial.
Eur Heart J
; 38(37): 2813-2822, 2017 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28575274
11.
Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial.
Eur Heart J
; 38(11): 804-810, 2017 Mar 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-28363222
12.
Atherothrombotic Risk Stratification and the Efficacy and Safety of Vorapaxar in Patients With Stable Ischemic Heart Disease and Previous Myocardial Infarction.
Circulation
; 134(4): 304-13, 2016 Jul 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-27440003
13.
Darapladib for preventing ischemic events in stable coronary heart disease.
N Engl J Med
; 370(18): 1702-11, 2014 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24678955
14.
Growth Differentiation Factor 15 Predicts All-Cause Morbidity and Mortality in Stable Coronary Heart Disease.
Clin Chem
; 63(1): 325-333, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-27811204
15.
The impact of atrial fibrillation type on the risk of thromboembolism, mortality, and bleeding: a systematic review and meta-analysis.
Eur Heart J
; 37(20): 1591-602, 2016 May 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-26888184
16.
Efficacy and safety of ticagrelor for long-term secondary prevention of atherothrombotic events in relation to renal function: insights from the PEGASUS-TIMI 54 trial.
Eur Heart J
; 37(4): 400-8, 2016 Jan 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-26443023
17.
Ischaemic risk and efficacy of ticagrelor in relation to time from P2Y12 inhibitor withdrawal in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54.
Eur Heart J
; 37(14): 1133-42, 2016 Apr 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-26491109
18.
Corrigendum to 'National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Management of Acute Coronary Syndromes 2016' Heart Lung and Circulation volume 25, (2016) 898 - 952.
Heart Lung Circ
; 26(10): 1117, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28867028
19.
Efficacy and Safety of Vorapaxar With and Without a Thienopyridine for Secondary Prevention in Patients With Previous Myocardial Infarction and No History of Stroke or Transient Ischemic Attack: Results from TRA 2°P-TIMI 50.
Circulation
; 132(20): 1871-9, 2015 Nov 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-26338971
20.
Albuminuria and cardiovascular events in patients with acute coronary syndromes: Results from the TRACER trial.
Am Heart J
; 178: 1-8, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-27502846